The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening.

about

The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening.

Item

http://www.wikidata.org/entity/Q47989482

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The hidden risk: Incorporating ...... nary artery disease screening.

@en

The hidden risk: Incorporating ...... nary artery disease screening.

@nl

type

Item

label

The hidden risk: Incorporating ...... nary artery disease screening.

@en

The hidden risk: Incorporating ...... nary artery disease screening.

@nl

prefLabel

The hidden risk: Incorporating ...... nary artery disease screening.

@en

The hidden risk: Incorporating ...... nary artery disease screening.

@nl

P1476

The hidden risk: Incorporating ...... nary artery disease screening.

@en

P2093

Edgar Turner Overton

http://www.w3.org/2001/XMLSchema#string

Gregory A Payne

http://www.w3.org/2001/XMLSchema#string

P2860

HIV infection and the risk of acute myocardial infarction.

Inflammation in atherosclerosis

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Optimal medical therapy with or without PCI for stable coronary disease.

Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.

Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

P2888

s12350-016-0731-9

P31

scholarly article

editorial

P356

10.1007/S12350-016-0731-9

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27853986

http://www.w3.org/2001/XMLSchema#string